triazoles has been researched along with Anemia, Aplastic in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (23.68) | 29.6817 |
| 2010's | 28 (73.68) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Han, B; Zhang, R | 1 |
| Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A | 1 |
| Berger, M; Calore, E; Carraro, F; Cesaro, S; Decembrino, N; Molinaro, M; Perruccio, K; Putti, MC; Rossin, S; Tridello, G; Vicenzi, EB | 1 |
| Hu, H; Liu, W; Wen, X; Wu, D; Ye, B; Zhou, Y | 1 |
| El-Ali, A; Ganser, A; Habr, D; Hsu, HC; Lee, JW; Martin, N; Porter, JB; Shen, ZX; Yoon, SS | 1 |
| Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B | 1 |
| Chung, J; Jang, JH; Jo, DY; Kim, HJ; Lee, JH; Lee, JW; Yoon, SS | 1 |
| Abe, T; Fujii, S; Fujita, M; Iyama, S; Jomen, W; Kato, J; Kobune, M; Kuroda, H; Maeda, M; Matsuno, T; Miyanishi, K; Nagashima, K; Sakurai, T; Sato, M; Yamada, M | 1 |
| Cheong, JW; Chung, J; Hyun, MS; Jo, DY; Joo, YD; Jung, CW; Kim, BS; Kim, CS; Kim, HJ; Kim, HY; Lee, JH; Lee, KH; Min, YH; Park, CY; Park, HS; Seong, CM; Shim, H; Sohn, SK; Yoon, HJ; Yoon, SS | 1 |
| Gamaletsou, MN; Walsh, TJ | 1 |
| Banerjee, A; Bentley, M; Bird, R; Forsyth, C; Grigg, A; Grigoriadis, G; Kellner, S; Mifsud, NA; Motum, P; Opat, S; Szer, J; Tam, C | 1 |
| Pajpani, M; Webb, R | 1 |
| Chaklader, M; Law, S | 1 |
| Bae, SH; Chung, JS; Hyun, MS; Joo, YD; Kim, H; Kim, HG; Kim, IH; Kim, SH; Kim, YS; Kwon, KY; Lee, GW; Lee, HS; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Park, KT; Ryoo, HM; Sohn, SK | 1 |
| Angelucci, E | 1 |
| Agaoglu, L; Glaser, S; Kilinç, Y; Kohgo, Y; Lim, LC; Miyamura, K; Urabe, A; Wang, C; Warzocha, K; Wiktor-Jedrzejczak, W | 1 |
| Bouchnerova, J; Hadrabova, M; Kocmanova, I; Lengerova, M; Mayer, J; Palackova, M; Pavlovsky, Z; Racil, Z; Ricna, D; Volfova, P; Weinbergerova, B | 1 |
| Chang, H; Hu, D; Hu, L; Huang, J; Liu, F; Nie, N; Quan, R; Shao, Y; Shi, J; Tang, X; Xiao, H; Zhang, F; Zhang, J; Zhang, L; Zheng, C; Zheng, Y; Zhou, Y | 1 |
| Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY | 1 |
| Akiti, T; Barreiros, G; Nouér, SA; Nucci, M; Trope, BM; Varon, AG | 1 |
| Hata, T; Ishikawa, T; Kato, J; Kondo, M; Miyazawa, K; Mori, H; Nakao, S; Ohyashiki, K; Omine, M; Ozawa, K; Rojkjaer, L; Taniguchi, J; Tanii, H; Tatsumi, Y; Urabe, A | 1 |
| Ito, Y; Kiguchi, T; Kimura, Y; Ohyashiki, K | 1 |
| Calado, RT; Kajigaya, S; Regal, JA; Stratakis, CA; Wilkerson, KL; Yewdell, WT; Young, NS | 1 |
| Alati, C; Marino, A; Nobile, F; Oliva, EN; Praticò, G; Ronco, F | 1 |
| Domokos, G; Ganser, A; Habr, D; Hsu, HC; Lee, JW; Porter, JB; Roubert, B; Shen, ZX; Yoon, SS | 1 |
| Im, HJ; Kim, BE; Koh, KN; Park, M; Seo, JJ | 1 |
| Ho, MW; Lin, HC; Lu, MY; Peng, CT; Weng, TF; Wu, KH | 1 |
| Melpignano, A; Quarta, A; Quarta, G | 1 |
| Bajwa, RP; Fung, B; Garee, A; Gross, TG; Pietryga, D; Rawlinson, NJ; Skeens, M; Soni, S; Termuhlen, AM | 1 |
| Cho, B; Chung, NG; Jang, PS; Jeong, DC; Kim, HK; Lee, JW | 1 |
| Cho, BS; Cho, SG; Eom, KS; Kim, DW; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, WS; Park, CW; Yahng, SA | 1 |
| Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW | 1 |
| Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L | 1 |
| Bigley, VH; Duarte, RF; Gosling, RD; Kibbler, CC; Potter, M; Seaton, S | 1 |
| Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
| Blackwood, RA; Klein, KC | 1 |
| Becker, M; Beske, F; Klingebiel, T; Lambrecht, E; Lehrnbecher, T; Porto, L; Rickerts, V; Schuster, T; Sörensen, J | 1 |
| Cimino, G; Gentile, G; Girmenia, C; Martino, P; Pizzarelli, G; Pozzi, E | 1 |
1 review(s) available for triazoles and Anemia, Aplastic
| Article | Year |
|---|---|
Treatment of fungal disease in the setting of neutropenia.
Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
6 trial(s) available for triazoles and Anemia, Aplastic
| Article | Year |
|---|---|
Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study.
Topics: Adolescent; Adult; Anemia, Aplastic; Benzoates; Blood Platelets; Child; Deferasirox; Female; Ferritins; Hemoglobins; Humans; Immunosuppressive Agents; Iron Chelating Agents; Male; Middle Aged; Neutrophils; Prospective Studies; Treatment Outcome; Triazoles; Young Adult | 2013 |
Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.
Topics: Adult; Aged; Anemia, Aplastic; Benzoates; Deferasirox; Female; Ferritins; Humans; Iron; Iron Overload; Liver; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Transfusion Reaction; Triazoles | 2014 |
Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Benzoates; Deferasirox; Erythrocyte Transfusion; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Triazoles | 2015 |
Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Benzoates; Child; Child, Preschool; Deferasirox; Humans; Iron Overload; Liver; Middle Aged; Myelodysplastic Syndromes; Triazoles | 2015 |
A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade, ICL670) in patients with transfusion-dependent anemias and iron-overload: a Phase I study in Japan.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Asian People; Benzoates; Blood Transfusion; Deferasirox; Dose-Response Relationship, Drug; Female; Humans; Iron Chelating Agents; Iron Overload; Japan; Male; Middle Aged; Myelodysplastic Syndromes; Triazoles | 2008 |
Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial.
Topics: Adolescent; Adult; Anemia, Aplastic; Benzoates; Chelation Therapy; Creatinine; Deferasirox; Female; Ferritins; Humans; Iron Chelating Agents; Male; Middle Aged; Prospective Studies; Triazoles; Young Adult | 2010 |
31 other study(ies) available for triazoles and Anemia, Aplastic
| Article | Year |
|---|---|
Dose of deferasirox correlates with its effects, which differ between low-risk myelodysplastic syndrome and aplastic anaemia.
Topics: Anemia, Aplastic; Benzoates; Creatinine; Deferasirox; Ferritins; Humans; Iron Chelating Agents; Iron Overload; Myelodysplastic Syndromes; Triazoles | 2022 |
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.
Topics: Administration, Oral; Adolescent; Anemia, Aplastic; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mycoses; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Triazoles | 2018 |
Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload.
Topics: Anemia, Aplastic; Animals; Benzoates; Deferasirox; Deferoxamine; Disease Models, Animal; Drug Therapy, Combination; Female; Iron Chelating Agents; Iron Overload; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Triazoles | 2018 |
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2014 |
Korean guideline for iron chelation therapy in transfusion-induced iron overload.
Topics: Anemia, Aplastic; Benzoates; Chelation Therapy; Deferasirox; Deferiprone; Humans; Iron Chelating Agents; Iron Overload; Myelodysplastic Syndromes; Pyridones; Republic of Korea; Transfusion Reaction; Triazoles | 2013 |
[Hematologic improvement with deferasirox following tandem antithymocyte globulin treatment in a transfusion-dependent patient with severe aplastic anemia].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Benzoates; Blood Transfusion; Cyclosporine; Deferasirox; Humans; Iron Chelating Agents; Male; Middle Aged; Transfusion Reaction; Treatment Outcome; Triazoles | 2013 |
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.
Topics: Anemia, Aplastic; Animals; Benzoates; Bone Marrow Cells; Cell Line; Cells, Cultured; Deferasirox; Deferoxamine; Gene Expression Regulation, Neoplastic; Humans; Iron Chelating Agents; Macrophages; Male; Mice; Myelodysplastic Syndromes; NF-kappa B; RNA, Long Noncoding; Transcription, Genetic; Triazoles; Tumor Necrosis Factor-alpha | 2015 |
Lingual necrosis caused by mucormycosis in a patient with aplastic anaemia: case report.
Topics: Aged, 80 and over; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Escherichia coli Infections; Fatal Outcome; Female; Humans; Immunocompromised Host; Mucormycosis; Necrosis; Rhizopus; Tongue; Triazoles | 2014 |
Alteration of hedgehog signaling by chronic exposure to different pesticide formulations and unveiling the regenerative potential of recombinant sonic hedgehog in mouse model of bone marrow aplasia.
Topics: Anemia, Aplastic; Animals; Bone Marrow Cells; Cell Cycle; Chlorpyrifos; Disease Models, Animal; Femur; Hedgehog Proteins; Humans; Male; Mice; Pesticides; Pyrethrins; Recombinant Proteins; Signal Transduction; Stromal Cells; Triazoles | 2015 |
Another Step Forward in Iron Chelation Therapy.
Topics: Anemia, Aplastic; Benzoates; Humans; Iron Overload; Liver; Myelodysplastic Syndromes; Triazoles | 2015 |
Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature.
Topics: Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Coinfection; Fatal Outcome; Fusariosis; Fusarium; Humans; Immunocompromised Host; Male; Opportunistic Infections; Triazoles; Young Adult | 2016 |
[Efficacy and safety of deferasirox in aplastic anemia patients with iron overload: a single arm, multi-center,prospective study in China].
Topics: Anemia, Aplastic; Benzoates; Blood Transfusion; China; Deferasirox; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Prospective Studies; Triazoles | 2016 |
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole | 2016 |
Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antifungal Agents; Female; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intertrigo; Leukemia; Male; Middle Aged; Onychomycosis; Prospective Studies; Skin; Triazoles; Voriconazole; Young Adult | 2016 |
Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload.
Topics: Anemia, Aplastic; Benzoates; Deferasirox; Female; Heart; Humans; Iron Chelating Agents; Magnetic Resonance Imaging; Triazoles; Young Adult | 2009 |
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anemia, Aplastic; Aromatase Inhibitors; Dyskeratosis Congenita; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Female; Flutamide; Gene Expression Regulation, Enzymologic; Hematopoietic Stem Cells; Heterozygote; Humans; Letrozole; Lymphocytes; Male; Mutation; Nitriles; Receptors, Androgen; Tamoxifen; Telomerase; Triazoles | 2009 |
Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients.
Topics: Anemia, Aplastic; Benzoates; Blood Transfusion; Deferasirox; Female; Hematopoiesis; Humans; Iron Chelating Agents; Male; Middle Aged; Myelodysplastic Syndromes; Triazoles | 2010 |
Restoration of hematopoiesis after iron chelation therapy with deferasirox in 2 children with severe aplastic anemia.
Topics: Anemia, Aplastic; Benzoates; Child; Deferasirox; Hematopoiesis; Humans; Iron Chelating Agents; Iron Overload; Male; Severity of Illness Index; Transfusion Reaction; Triazoles | 2010 |
Successful treatment of disseminated mixed invasive fungal infection after hematopoietic stem cell transplantation for severe aplastic anemia.
Topics: Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Mucormycosis; Rhizopus; Triazoles | 2012 |
Oral iron chelator deferasirox in the treatment of secondary hemochromatosis following bone marrow transplantation in a patient with severe aplastic anemia.
Topics: Adult; Anemia, Aplastic; Benzoates; Bone Marrow Transplantation; Deferasirox; Ferritins; Hemochromatosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Male; Triazoles | 2011 |
Disseminated Rhizomucor pusillus causing early multiorgan failure during hematopoietic stem cell transplantation for severe aplastic anemia.
Topics: Amphotericin B; Anemia, Aplastic; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Mucormycosis; Multiple Organ Failure; Pyrimidines; Rhizomucor; Triazoles; Voriconazole | 2011 |
Iron chelation therapy with deferasirox results in recovery of hematopoiesis in a child with aplastic anemia.
Topics: Anemia, Aplastic; Benzoates; Child, Preschool; Deferasirox; Hematopoiesis; Humans; Iron Chelating Agents; Male; Treatment Outcome; Triazoles | 2011 |
Improvement in hematopoiesis after iron chelation therapy with deferasirox in patients with aplastic anemia.
Topics: Adult; Anemia, Aplastic; Benzoates; Chelation Therapy; Deferasirox; Erythrocyte Transfusion; Female; Ferritins; Hematopoiesis; Humans; Immunosuppressive Agents; Iron; Iron Chelating Agents; Iron Overload; Male; Platelet Transfusion; Transfusion Reaction; Triazoles | 2013 |
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole | 2013 |
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.
Topics: Adult; Anemia, Aplastic; Antifungal Agents; Female; Fusarium; Humans; Mycoses; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Rhinocerebral zygomycosis in a young girl undergoing allogeneic stem cell transplantation for severe aplastic anaemia.
Topics: Absidia; Alternaria; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Central Nervous System Fungal Infections; Child; Female; Humans; Radiography; Sinusitis; Stem Cell Transplantation; Telencephalon; Transplantation, Homologous; Triazoles; Zygomycosis | 2006 |
Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Aspergillosis; Child; Cohort Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |